Bitcoin price recovered to around $83,200 on October 13 after dipping to about $81,034, but faced resistance near $84,000, preventing a sustained rally. Technical indicators show weak momentum with the daily MACD below its signal line and Bitcoin trading just below its 20-day moving average. Analyst Ella highlights $84,000 as a key recovery level and $82,300 as support, while whale activity has increased, suggesting potential for another upward move. However, liquidation clusters above $84,600 pose additional hurdles, leaving the near-term outlook cautious until Bitcoin can decisively break above $84,000.
Bitcoin price moves are the subject here, with Pluang market data providing context. For readers following major cryptocurrencies, 16 out of 50 rose and 33 fell today. Notable movers include ZIL at Rp61 with a 1-day change of -4.71% and Pluang order activity of 99% Sell / 1% Buy, DOT at Rp20,793 with -4.68% change and 64% Sell / 36% Buy, and KSM at Rp83,651 with -4.58% change and 90% Sell / 10% Buy. This snapshot is as of Oct 14, 2026 00:03 WIB.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
